≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Other and unspecified primary disorders of muscles

DOID EFO Endpoint Browser PheWeb

G6_MUSCOTHUNS

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

2 out of 7 registries used, show all original rules.

264

4. Check minimum number of events

None

264

5. Include endpoints

None

264

6. Filter based on genotype QC (FinnGen only)

264

Control definitions (FinnGen only)

Control exclude
G6_MYONEU

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 1716 804 901
Only index persons 1507 719 788
Unadjusted period prevalence (%)
Whole population 0.02 0.02 0.03
Only index persons 0.03 0.03 0.03
Median age at first event (years)
Whole population 51.52 52.43 50.70
Only index persons 51.61 52.14 51.12

-FinnGen-

Key figures

All Female Male
Number of individuals 264 137 127
Unadjusted period prevalence (%) 0.05 0.05 0.06
Median age at first event (years) 51.61 51.78 51.44

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
242
Matched controls
2421
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G71.9
ICD-10 Finland
Primary disorder of muscle, unspecified
+∞
210.3
170
*
G71.8
ICD-10 Finland
Other primary disorders of muscles
+∞
103.8
92
*
G72.9
ICD-10 Finland
Myopathy, unspecified
593.0
84.6
79
*
G71.08
ICD-10 Finland
Other muscular dystrophy
+∞
64.5
59
*
G71.18
ICD-10 Finland
Other myotonic disease
+∞
34.2
32
*
R1250
NOMESCO Finland
Evaluation of functional capability
30.6
30.9
41
16
NJ3CG
NOMESCO Finland
Extensive MRI examination of extremities with median high magnet
118.0
29.4
31
*
NXL00
NOMESCO Finland
Biopsy of muscle
73.3
28.7
32
5
Z31.5
ICD-10 Finland
Genetic counselling
10.8
27.4
55
64
G72.8
ICD-10 Finland
Other specified myopathies
+∞
24.4
23
*
L28
ICPC
Limited function/disability (L)
5.1
19.8
70
179
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
6.4
19.3
54
104
G71.00
ICD-10 Finland
Muscular dystrophy benign [Becker]
+∞
19.0
18
*
G71.3
ICD-10 Finland
Mitochondrial myopathy, not elsewhere classified
+∞
19.0
18
*
N03AE01
ATC
clonazepam; systemic
7.4
17.4
43
69
M60.8
ICD-10 Finland
Other myositis
+∞
16.9
16
*
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
7.4
16.7
41
65
NJ3BG
NOMESCO Finland
MRI examination of extremities with high intensity magnet
43.4
16.6
20
5
SPAT1229
SPAT
Assessment of need for aid
6.2
14.8
41
77
G71.0
ICD-10 Finland
Muscular dystrophy
+∞
14.7
14
*
G71.11
ICD-10 Finland
Dystrophia myotonica [Steinert]
+∞
14.7
14
*
J96.1
ICD-10 Finland
Chronic respiratory failure
17.2
14.2
22
14
N99
ICPC
Neurological disease other
32.2
14.1
18
6
NGA20
NOMESCO Finland
Exploration of soft tissue knee or lower leg, open
79.8
13.7
15
*
G71.12
ICD-10 Finland
Myotonia congenita
+∞
13.7
13
*
M60.9
ICD-10 Finland
Myositis, unspecified
53.0
13.0
15
*
N18
ICPC
Paralysis/weakness
21.5
12.7
18
9
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
4.1
12.6
53
156
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
11.4
12.0
22
21
C10AX09
ATC
ezetimibe; oral
4.7
12.0
42
103
M62.9
ICD-10 Finland
Disorder of muscle, unspecified
68.4
11.7
13
*
G71.06
ICD-10 Finland
Muscular dystrophy severe [Duchenne]
+∞
11.5
11
*
R4120
NOMESCO Finland
Occupational therapy
5.4
11.4
35
74
L99
ICPC
Musculoskeletal disease other
16.5
11.0
17
11
R13
ICD-10 Finland
Dysphagia
5.3
10.8
33
70
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
4.3
10.6
40
106
M33.2
ICD-10 Finland
Polymyositis
114.8
10.5
11
*
N28
ICPC
Limited function/disability (N)
17.0
10.5
16
10
G71.28
ICD-10 Finland
Other congenital myopathy
+∞
10.5
10
*
N03AX12
ATC
gabapentin; oral
3.5
10.1
50
168
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
3.2
9.9
58
219
R4110
NOMESCO Finland
Physiotherapy
2.7
9.9
86
416
N29
ICPC
Neurological sympt/complt other
14.2
9.8
16
12
XF404
NOMESCO Finland
Ambulatory ECG
4.2
9.8
38
103
N03AX16
ATC
pregabalin; oral
2.8
9.7
73
325
G71.25
ICD-10 Finland
Congenital muscular dystrophy NOS
+∞
9.4
9
*
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.6
9.3
81
389
I42.9
ICD-10 Finland
Cardiomyopathy, unspecified
14.4
9.3
15
11
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
4.0
8.8
35
97
N07AA02
ATC
pyridostigmine; systemic
51.9
8.7
10
*
N03AF01
ATC
carbamazepine; oral, rectal
6.1
8.7
23
41
L19
ICPC
Muscle symptom/complaint NOS
9.5
8.7
17
19
NJ3DG
NOMESCO Finland
Very extensive MRI examination of extremities with high intensity magnet
93.2
8.5
9
*
33030
ICD-8 Finland
Hereditary neuromuscular disorders, Progressive muscular dystrophy
+∞
8.4
8
*
M03BX01
ATC
baclofen; systemic
15.2
8.3
13
9
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.7
8.3
64
285
Z50.1
ICD-10 Finland
Other physical therapy
4.9
8.2
26
58
RF410
NOMESCO Finland
NA
34.6
8.1
10
*
A28
ICPC
Limited function/disability NOS
3.2
8.1
44
156
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.8
7.8
52
213
TAW99
NOMESCO Finland
Other minor neurosurgical procedure
46.5
7.8
9
*
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.3
7.6
38
128
XA402
NOMESCO Finland
ENMG
8.1
7.5
16
21
QDA99
NOMESCO Finland
Other local destruction of skin of lower limb
82.5
7.5
8
*
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
3.3
7.5
38
130
3591A
ICD-9 Finland
Muscular dystrophies and other myopathies, Hereditary progressive muscular dystrophy
+∞
7.3
7
*
Z99.1
ICD-10 Finland
Dependence on respirator
+∞
7.3
7
*
M41.4
ICD-10 Finland
Neuromuscular scoliosis
+∞
7.3
7
*
33098
ICD-8 Finland
Hereditary neuromuscular disorders, Alii definiti
+∞
7.3
7
*
R06.0
ICD-10 Finland
Dyspnoea
2.4
7.3
68
335
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
31.0
7.2
9
*
G47.3
ICD-10 Finland
Sleep apnoea
2.5
7.2
63
301
H02AB06
ATC
prednisolone; systemic
2.1
7.1
121
784
R52.2
ICD-10 Finland
Other chronic pain
5.1
7.0
21
44
RF420
NOMESCO Finland
NA
14.3
7.0
11
8
JDB10
NOMESCO Finland
Percutaneous gastrostomy
14.3
7.0
11
8
SPAT1231
SPAT
Assessment of adjustments needed in living environment
9.7
6.9
13
14
N06AX21
ATC
duloxetine; oral
3.3
6.8
33
109
RF120
NOMESCO Finland
NA
17.3
6.8
10
6
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.8
6.8
28
81
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
4.0
6.6
25
67
ZX120
NOMESCO Finland
Intravenous
3.1
6.3
35
125
SPAT1215
SPAT
Assessment of need for medical rehabilitation
5.3
6.3
18
36
TJD20
NOMESCO Finland
Change of gastrostomy tube
18.6
6.3
9
5
3599X
ICD-9 Finland
Muscular dystrophies and other myopathies, Myopathy, unspecified
+∞
6.3
6
*
SPAT1216
SPAT
Assessment of functional ability
2.7
6.0
41
169

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
46
14
39.58
73.07
1.5
1.6
u/l
7.4
8.3
0.11
40
14
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
175
588
6.86
52.92
4.3
2.1
u/l
1139.1
168.5
2.04
169
551
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
22
14
17.05
25.68
1.3
1.1
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
117
514
3.29
19.67
3.7
3.4
ng/l
1281.6
1198.5
0.05
110
438
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
171
1005
2.99
16.21
8.4
8.2
mmol/l
1.2
1.2
0.03
153
866
(3037522) Nuclear Ab [Titer] in Serum
75
283
3.31
15.76
1.5
1.4
titre
509.6
551.9
0.09
23
64
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
159
929
2.79
14.72
8.8
7.3
mmol/l
1.2
1.2
0.37
152
853
(3002032) Base excess in Venous blood by calculation
56
215
3.04
11.13
6.8
5.9
mmol/l
2.3
1.9
0.35
48
176
(3024561) Albumin [Mass/volume] in Serum or Plasma
142
867
2.38
10.82
5.8
5.4
g/l
36.2
36.1
0.09
137
814
(3021447) Carbon dioxide [Partial pressure] in Venous blood
56
219
2.98
10.75
6.8
5.8
kpa
6.2
5.8
2.18
56
213
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
128
753
2.36
10.55
4.3
3.1
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
42
140
3.38
10.52
3.3
3.5
ng/l
138.9
186.4
0.33
36
127
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
139
850
2.34
10.44
3.8
2.4
nmol/l
78.0
76.2
0.28
132
761
(3018418) pH of Serum or Plasma
109
602
2.38
10.34
5.2
3.9
ph
7.4
7.4
0.74
18
105
(3000991) Gas panel - Venous blood
50
199
2.87
9.23
11.5
9.2
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
212
1627
2.54
8.54
11.0
7.4
u/l
81.9
82.8
0.10
203
1526
(3002582) Erythrocytes [#/volume] in Urine
110
652
2.18
8.45
3.7
3.0
e6/l
43.7
45.3
0.02
89
499
(3030467) Casts [#/volume] in Urine by Automated count
103
597
2.19
8.35
3.6
2.9
e6/l
0.6
0.4
0.27
82
441
(3026008) Bacteria identified in Urine by Culture
97
549
2.21
8.34
3.6
2.9
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
47
191
2.78
8.31
5.5
5.6
kpa
4.6
4.7
0.07
47
186
(3009261) Glucose [Presence] in Urine by Test strip
151
1016
2.14
8.30
4.8
3.4
estimate
0.0
0.0
0.00
32
176
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
75
384
2.33
8.18
4.2
3.7
ng/l
78.4
264.6
1.57
65
285
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
10
11
9.41
8.13
3.7
3.6
ug/l
87.6
151.8
—
10
11
(3020891) Body temperature
27
80
3.65
8.04
7.2
4.5
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
121
756
2.11
8.00
4.6
3.5
e6/l
36.9
55.5
0.51
94
532
(3021601) Nitrite [Presence] in Urine by Test strip
149
1007
2.10
7.98
6.1
4.7
estimate
0.0
0.0
0.00
33
191
(3003396) Base excess in Arterial blood by calculation
52
228
2.59
7.91
8.1
10.0
mmol/l
1.6
1.4
0.06
39
191
(36304419) Bacteria [Presence] in Urine
101
595
2.13
7.74
3.5
2.9
—
—
—
0
0
(3015736) pH of Urine
123
786
2.06
7.54
4.5
3.2
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
34
122
3.05
7.50
2.0
3.0
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
170
1229
2.08
7.34
7.6
5.4
mmol/l
6.1
6.6
4.76
162
1149
(40758558) Short blood count panel - Blood
98
581
2.09
7.31
7.8
7.9
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
83
465
2.14
7.16
5.1
3.6
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
146
1010
2.00
7.00
4.9
3.4
estimate
0.0
0.0
0.00
31
187
(3015377) Calcium [Moles/volume] in Serum or Plasma
109
683
2.01
6.91
3.3
3.5
mmol/l
2.4
2.4
1.20
100
602
(3015171) Extractable nuclear Ab [Units/volume] in Serum
25
78
3.44
6.89
1.3
1.3
u/ml
0.2
1.6
—
5
6
(3037467) Urinalysis macro (dipstick) panel - Urine
187
1418
2.09
6.86
4.8
4.1
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
156
1111
1.99
6.81
7.5
6.8
umol/l
13.0
12.4
0.14
148
1050
(3013115) Eosinophils [#/volume] in Blood
159
1143
1.98
6.72
10.2
7.4
e9/l
0.2
0.2
0.54
143
1010
(3019060) Gas panel - Arterial blood
35
136
2.81
6.69
4.7
7.8
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
20
55
3.85
6.61
1.5
1.5
iu/ml
0.2
0.1
—
7
10
(3001604) Monocytes [#/volume] in Blood
155
1114
1.95
6.45
9.4
6.9
e9/l
0.6
0.6
0.05
139
963
(3006315) Basophils [#/volume] in Blood
155
1117
1.94
6.37
9.4
6.9
e9/l
0.0
0.0
0.15
139
970
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
11
19
6.00
6.16
1.1
1.0
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
155
1138
1.88
5.80
9.5
6.9
e9/l
1.9
1.9
0.54
138
1014
(3009343) pH of Capillary blood
40
179
2.46
5.78
5.1
4.9
ph
7.4
7.4
—
9
13
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
62
335
2.11
5.74
2.8
2.8
e6/l
2.5
2.0
0.21
40
179
(3000850) Epithelial cells [#/volume] in Urine
75
435
2.01
5.74
3.4
2.5
e6/l
7.5
4.8
0.69
70
387
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
39
174
2.46
5.67
5.2
4.9
mmol/l
1.8
1.4
0.27
34
128
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
37
161
2.51
5.67
2.3
2.7
ml/min/173m2
67.8
66.5
—
9
68
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
64
352
2.08
5.65
3.3
2.7
mmol/l
2.5
2.4
1.13
58
301
(3028626) Oxygen [Partial pressure] in Capillary blood
28
107
2.81
5.52
4.0
5.1
kpa
9.7
9.0
1.12
28
102
(3013650) Neutrophils [#/volume] in Blood by Automated count
170
1299
1.87
5.46
11.5
10.3
e9/l
4.0
4.0
0.15
154
1128
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
65
364
2.04
5.46
3.0
2.6
e6/l
0.8
0.8
0.04
44
206
(3013707) Erythrocyte sedimentation rate by Westergren method
195
1562
1.95
5.36
6.0
4.2
mm/h
11.5
10.6
0.40
183
1431
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
110
740
1.83
5.32
2.2
1.8
pmol/l
87.9
98.4
1.86
54
366
(3052851) Hemolysis interference index of Serum or Plasma
20
65
3.25
5.18
2.8
2.3
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
48
244
2.18
5.16
3.1
1.6
—
—
—
0
0
(4035726)
38
175
2.37
5.15
1.9
1.4
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
58
319
2.05
5.09
2.0
2.0
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
114
785
1.80
5.04
5.3
3.4
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
13
32
4.22
4.95
1.2
1.1
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
17
53
3.36
4.70
1.8
1.2
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
73
446
1.88
4.70
2.1
2.2
mg/l
2.5
1.2
0.46
57
352
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
12
30
4.14
4.48
1.2
1.1
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
25
101
2.63
4.45
3.4
4.8
%
1.9
1.2
1.26
25
101
(3021589) Normoblasts [#/volume] in Blood
137
1020
1.71
4.44
14.0
9.6
e9/l
0.0
0.0
0.41
112
823
(40761535) Cells panel - Urine sediment
35
166
2.28
4.43
5.7
3.7
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
108
754
1.73
4.42
4.4
3.5
ng/l
58.0
35.4
0.76
88
500
(3023368) Bacteria identified in Blood by Culture
82
530
1.79
4.37
9.2
4.3
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
20
73
2.88
4.29
1.7
2.2
ug/l
2.2
4.3
0.22
20
66
(3018677) aPTT in Platelet poor plasma by Coagulation assay
56
324
1.92
4.22
2.9
2.6
s
30.3
29.6
0.48
56
318
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
94
638
1.74
4.21
2.7
2.6
u/l
54.3
56.7
0.35
88
592
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
11
27
4.21
4.20
1.5
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
11
27
4.21
4.20
1.5
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
11
27
4.21
4.20
1.5
1.2
—
—
—
0
0
(3022229) Phosphate [Moles/volume] in Urine
7
7
10.23
4.03
3.0
3.7
mmol/l
13.6
18.9
—
7
7
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
11
28
4.06
4.02
1.5
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
11
28
4.06
4.02
1.5
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
11
28
4.06
4.02
1.5
1.2
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
13
38
3.55
3.95
1.8
2.5
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
19
71
2.81
3.92
3.4
2.8
—
—
—
0
0
(3026782) Osmolality of Urine
65
408
1.79
3.77
2.9
2.6
mosm/kgh2o
577.7
553.8
0.34
57
349
(3028026) IgM [Mass/volume] in Serum or Plasma
32
157
2.18
3.75
1.8
1.8
g/l
1.1
1.3
0.45
32
145
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
42
229
1.99
3.74
1.8
1.9
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
40
215
2.01
3.70
25.5
18.7
inr
1.2
1.2
—
8
24
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
13
40
3.37
3.67
1.0
1.1
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
76
503
1.72
3.66
2.8
2.3
mg/l
3.0
3.2
0.14
70
428
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
19
74
2.69
3.64
1.4
1.9
—
244.0
—
0
5
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
19
75
2.65
3.55
1.6
2.4
—
—
—
0
0
(1616796) Gas panel - Central venous blood
13
41
3.28
3.54
5.5
2.5
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
34
176
2.07
3.48
10.0
8.9
mmol/l
25.8
25.1
0.46
34
176
(40760892) CBC W Ordered Manual Differential panel - Blood
74
493
1.70
3.46
5.0
5.1
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
221
1942
1.85
3.39
18.5
11.7
ml/min/173m2
96.3
84.4
5.82
193
1567
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
8
14
5.85
3.36
5.3
3.7
umol/l
35.9
26.3
—
8
14
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
192
1626
1.66
3.33
4.8
3.8
pmol/l
15.2
14.6
2.01
181
1476
(3029937) Albumin [Presence] in Urine by Test strip
78
533
1.66
3.29
6.1
3.7
estimate
0.0
0.0
0.68
32
186
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
18
72
2.61
3.29
1.4
2.6
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
26
124
2.22
3.27
1.6
1.3
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
29
145
2.12
3.25
1.2
1.4
u/ml
323.0
355.6
0.05
29
130
(3044889) 12 lead EKG panel
174
1444
1.60
3.22
4.4
3.6
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
21
92
2.39
3.19
3.9
3.2
%
53.2
51.6
0.10
21
92
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
218
1918
1.78
3.19
5.4
5.4
mmol/mol
38.5
39.5
0.82
206
1804
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
15
56
2.78
3.11
1.3
2.8
g/l
40.8
38.9
0.71
15
49
(3016018) Differential panel - Cerebral spinal fluid
8
16
5.12
3.07
2.3
2.9
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
12
40
3.10
3.01
7.0
2.7
kpa
5.5
5.0
1.02
12
40
(3027315) Oxygen [Partial pressure] in Blood
12
40
3.10
3.01
7.0
2.7
kpa
9.1
8.3
0.92
12
40
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
220
1951
1.77
3.00
5.8
4.5
mu/l
1.9
1.9
0.26
209
1788
(3019069) Monocytes/100 leukocytes in Blood
133
1052
1.53
2.94
9.7
7.4
%
8.6
8.5
0.03
133
990
(3006504) Eosinophils/100 leukocytes in Blood
132
1045
1.53
2.89
9.6
7.1
%
2.7
3.0
0.96
132
977
(3022313) Gas panel - Capillary blood
28
145
2.04
2.88
5.9
5.2
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
53
338
1.71
2.87
2.0
1.6
nmol/l
1385.2
1224.9
0.40
42
256
(3016650) Hepatitis A virus Ab [Presence] in Serum
13
47
2.86
2.86
1.0
1.1
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
129
1019
1.52
2.84
9.6
7.1
%
0.6
0.7
0.69
129
954
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
9
23
4.01
2.80
1.3
1.9
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
9
23
4.01
2.80
1.3
1.9
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
9
23
4.01
2.80
1.3
1.9
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
239
2186
1.99
2.77
21.5
13.0
mg/l
19.7
22.3
0.71
205
1675
(3044290) Cell count panel - Cerebral spinal fluid
13
48
2.80
2.76
2.0
2.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
19
86
2.30
2.71
1.4
1.6
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
8
19
4.31
2.70
3.9
1.6
umol/l
28.0
16.4
—
8
19
(3019150) Specific gravity of Urine by Refractometry
65
446
1.61
2.65
6.2
3.6
kg/l
1.0
1.0
—
9
52
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
38
225
1.80
2.65
1.8
1.9
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
25
129
2.04
2.60
1.6
1.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
28
152
1.94
2.54
1.3
1.6
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
11
39
2.90
2.50
1.2
2.2
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
9
26
3.55
2.50
1.1
2.1
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
7
16
4.46
2.49
1.3
2.1
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
8
21
3.89
2.48
1.4
1.2
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
10
34
3.02
2.44
1.6
1.9
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
15
64
2.42
2.43
1.5
2.0
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
79
578
1.52
2.42
3.7
2.8
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
6
12
5.09
2.41
1.5
1.9
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
6
12
5.09
2.41
1.5
1.9
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
6
12
5.09
2.41
1.5
1.9
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
6
12
5.09
2.41
1.5
1.9
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
28
155
1.90
2.41
1.6
1.2
iu/ml
100.6
176.7
—
8
63
(3042936) Bacteria identified in Isolate by Culture
48
314
1.65
2.36
2.4
2.2
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
71
512
1.53
2.32
2.6
3.1
umol/l
335.7
6159.6
1.98
61
442
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
25
135
1.94
2.31
6.2
5.4
mmol/l
24.6
24.5
0.06
25
130
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
15
66
2.35
2.29
1.3
2.0
—
—
—
0
0
(4027681)
8
23
3.55
2.29
1.0
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
6
13
4.70
2.28
1.0
1.0
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
70
505
1.53
2.28
1.6
1.5
g/l
2.1
2.3
0.30
43
295
(3001122) Ferritin [Mass/volume] in Serum or Plasma
113
898
1.45
2.28
3.6
2.8
ug/l
124.0
109.0
0.29
107
838
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
7
18
3.96
2.26
3.0
1.6
mg/l
2.3
3.0
—
7
18
(3002385) Erythrocyte distribution width [Ratio]
211
1893
1.57
2.26
23.3
16.4
%
13.9
13.6
1.61
206
1863
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
9
29
3.18
2.24
1.7
2.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
43
277
1.66
2.24
1.3
1.2
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
5
9
5.64
2.22
1.6
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
5
9
5.64
2.22
1.6
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
5
9
5.64
2.22
1.6
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
5
9
5.64
2.22
1.6
1.0
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
7
19
3.75
2.16
1.3
2.4
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
6
14
4.36
2.16
1.0
1.1
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
6
14
4.36
2.16
1.0
1.2
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
40
257
1.66
2.11
1.5
1.7
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
104
823
1.44
2.11
2.3
2.0
—
—
—
0
0
(4062490)
8
25
3.27
2.11
2.0
1.3
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
13
56
2.39
2.08
1.6
1.6
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
7
20
3.57
2.07
1.3
2.3
ug/l
24.2
18.0
—
7
20
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
6
15
4.07
2.05
1.0
1.3
mmol/l
1.9
1.7
—
6
15
(42870588) Differential panel, method unspecified - Blood
96
752
1.43
2.05
10.0
6.9
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
11
44
2.57
2.04
1.1
2.0
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
45
301
1.60
2.03
1.6
1.6
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
13
57
2.35
2.01
1.6
1.6
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
19
99
1.99
1.96
1.5
1.4
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
8
27
3.02
1.95
1.3
5.0
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
6
16
3.81
1.94
1.0
1.0
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
14
65
2.22
1.91
1.4
1.4
ug/g
258.0
311.4
—
9
36
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
14
65
2.22
1.91
1.5
1.6
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
17
86
2.04
1.89
3.2
5.6
g/l
0.2
0.2
—
10
43
(3021960) Folate [Moles/volume] in Serum or Plasma
61
444
1.49
1.89
1.8
1.5
nmol/l
23.1
22.2
0.15
53
369
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
34
2.70
1.88
1.0
2.0
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
27
161
1.75
1.87
4.0
5.1
%
0.0
0.0
—
5
46
(3011648) Oxygen content in Venous blood
6
17
3.59
1.85
3.7
15.1
%
13.1
12.1
—
6
17
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
7
23
3.10
1.81
1.0
1.0
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
81
628
1.42
1.80
3.3
3.3
mmol/l
7.0
7.9
1.00
76
536
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
15
74
2.09
1.79
2.2
2.1
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
10
41
2.50
1.77
1.5
5.6
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
13
61
2.19
1.74
1.5
1.3
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
7
24
2.97
1.73
1.7
4.4
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
5
13
3.90
1.72
1.4
1.2
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
21
119
1.83
1.72
4.3
3.4
pmol/l
4.8
4.6
0.21
21
106
(3044640) Blood type and Crossmatch panel - Blood
81
633
1.40
1.71
3.4
2.5
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
13
62
2.15
1.68
1.7
1.5
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
8
31
2.63
1.67
1.6
1.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
6
19
3.21
1.67
1.5
1.1
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
6
19
3.21
1.67
2.8
3.3
e6/l
93.3
338.9
—
6
9
(3019225) pH of Specimen
27
168
1.68
1.63
3.4
5.0
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
27
168
1.68
1.63
3.9
5.1
%
0.0
0.1
—
5
52
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
5
14
3.62
1.62
1.2
3.4
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
5
14
3.62
1.62
1.2
3.4
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
7
26
2.74
1.59
1.1
1.2
nmol/l
—
—
—
0
0
(3013512) EKG study
69
531
1.41
1.58
3.6
3.5
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
39
268
1.53
1.58
7.6
4.1
umol/l
6.1
9.0
0.97
29
239
(3028433) Virus identified in Specimen by Culture
5
15
3.38
1.53
1.0
1.3
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
5
15
3.38
1.53
1.0
1.8
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
19
109
1.80
1.51
1.4
1.6
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
20
117
1.77
1.50
1.2
1.6
iu/l
13.1
25.4
1.19
13
94
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
62
473
1.41
1.49
3.2
2.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
65
822
0.72
1.47
2.7
2.7
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
9
38
2.42
1.47
1.0
2.0
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
9
39
2.35
1.44
1.4
1.1
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
6
22
2.77
1.44
2.8
3.5
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
9
40
2.29
1.41
3.8
6.5
—
3607.1
—
0
7
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
111
936
1.32
1.40
4.2
4.1
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
11
53
2.12
1.40
4.0
3.2
u/ml
0.3
0.3
—
5
30
(3049717) Cytology report of Urine Cyto stain
12
60
2.05
1.40
2.3
3.0
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
12
60
2.05
1.40
1.8
1.5
u/ml
109.3
259.4
—
6
31
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
7
29
2.45
1.40
2.9
3.0
e6/l
322.3
591.8
—
7
22
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
7
29
2.45
1.40
2.7
3.0
e9/l
0.2
0.2
—
7
22
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
19
112
1.75
1.39
2.7
2.4
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
9
41
2.24
1.38
3.6
8.1
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
26
168
1.61
1.38
4.0
4.9
%
4.8
0.3
—
5
42
(3017817) Protein [Mass] in Urine collected for unspecified duration
5
17
2.98
1.36
2.4
3.9
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
94
778
1.32
1.35
10.1
7.4
inr
1.3
1.2
0.33
31
227
(3000494) Fungus identified in Specimen by Culture
37
262
1.48
1.32
1.4
1.6
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
6
24
2.53
1.31
1.2
1.3
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
34
237
1.50
1.31
13.2
7.9
—
—
—
0
0
(44790048)
8
34
2.39
1.30
1.0
2.0
—
—
—
0
0
(44790047)
8
34
2.39
1.30
1.0
2.0
—
—
—
0
0
(44806118)
8
34
2.39
1.30
1.0
2.0
—
—
—
0
0
(44790049)
8
34
2.39
1.30
1.0
2.0
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
8
34
2.39
1.30
1.0
2.1
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
12
62
1.98
1.30
2.4
1.2
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
10
48
2.13
1.29
1.0
1.9
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
5
18
2.81
1.29
1.2
1.1
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
6
25
2.43
1.25
2.3
1.8
%
87.6
90.5
—
6
25
(3017181) Myelocytes/100 leukocytes in Blood
27
181
1.55
1.24
4.0
4.9
%
1.6
0.7
—
5
59
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
10
49
2.08
1.23
1.2
2.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
12
211
0.55
1.23
1.2
1.7
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
13
71
1.87
1.21
2.1
1.9
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
68
546
1.33
1.19
1.2
1.4
u/ml
0.8
1.4
0.93
12
146
(3022621) pH of Urine by Test strip
20
126
1.64
1.18
2.8
2.3
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
5
20
2.53
1.15
2.4
3.7
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
7
30
2.37
1.13
2.4
2.6
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
8
40
2.03
1.13
1.8
1.4
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
43
325
1.39
1.10
1.2
1.2
u/ml
3.4
7.0
0.63
24
128
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
61
489
1.32
1.08
4.4
3.9
%
23.6
22.1
0.27
21
208
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
44
336
1.37
1.06
1.3
1.3
iu/ml
20.4
29.3
—
9
122
(3009214) Lutropin [Units/volume] in Serum or Plasma
14
83
1.73
1.03
1.5
1.6
u/l
6.5
8.4
—
9
60
(3012516) Albumin [Mass/volume] in Urine
67
548
1.30
1.03
3.0
3.2
mg/l
568.3
283.0
0.21
52
358
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
5
23
2.20
0.98
1.4
1.3
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
27
192
1.45
0.97
1.7
4.4
ug/l
31.6
28.7
0.03
18
151
(3035637) Corticotropin [Mass/volume] in Plasma
7
37
1.92
0.94
1.4
1.4
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
73
611
1.27
0.93
4.3
4.2
ug/l
1.7
1.8
0.29
68
546
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
6
28
2.17
0.92
1.2
1.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
6
29
2.09
0.90
1.8
1.4
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
6
29
2.09
0.90
1.2
1.2
—
—
—
0
0
(4034850)
12
72
1.70
0.86
22.3
10.8
—
—
—
0
0
(40768443) Skin Pathology biopsy report
13
80
1.66
0.86
1.1
1.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
9
149
0.59
0.81
1.1
1.4
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
12
74
1.65
0.79
1.4
1.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
237
2284
1.37
0.79
17.6
11.8
—
—
—
0
0
(4306422)
6
34
1.78
0.77
1.3
1.3
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
21
150
1.43
0.76
2.1
1.5
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
5
24
2.10
0.75
1.2
1.5
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
5
24
2.10
0.75
4.0
3.3
—
39.7
—
0
7
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
9
55
1.66
0.74
2.2
1.4
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
7
39
1.82
0.73
1.4
1.2
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
5
25
2.02
0.73
1.2
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
12
76
1.61
0.73
1.4
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
7
40
1.77
0.72
1.6
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
7
40
1.77
0.72
1.6
1.3
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
17
118
1.47
0.71
1.2
1.2
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
5
26
1.94
0.71
2.2
1.2
—
—
—
0
0
(3000492) Spirometry study
27
205
1.35
0.70
1.6
1.5
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
12
77
1.59
0.70
1.4
1.2
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
5
27
1.87
0.69
1.6
1.4
—
—
—
0
0
(4268621)
5
27
1.87
0.69
2.0
1.9
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
212
2024
1.24
0.68
4.6
4.2
mmol/l
5.8
5.9
0.73
200
1868
(3030905) Polymorphonuclear cells [#/volume] in Blood
7
43
1.64
0.67
2.4
2.6
e9/l
3.6
5.0
—
7
43
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
7
44
1.61
0.65
2.7
3.1
%
57.7
58.7
—
7
44
(4010399)
21
155
1.39
0.65
1.6
1.4
—
—
—
0
0
(3002256) Pathology report gross observation
32
253
1.30
0.65
1.1
1.2
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
21
0.00
0.60
0.0
1.3
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
0
22
0.00
0.59
0.0
1.9
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
0
22
0.00
0.59
0.0
1.4
—
8.5
—
0
6
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
55
470
1.22
0.59
1.7
1.6
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
200
2084
0.83
0.58
23.2
14.5
%
40.2
40.6
0.28
149
1613
(36660697) Celiac disease serology panel - Serum
26
203
1.31
0.58
1.1
1.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
66
576
1.19
0.57
3.5
4.0
mg/mmol
5.5
8.6
0.61
49
376
(21494755) Public health laboratory ask at order entry panel
19
250
0.74
0.57
1.3
1.4
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
6
36
1.68
0.57
1.2
3.1
u/ml
18.7
28.8
—
6
36
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
6
37
1.64
0.56
1.0
1.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
6
39
1.55
0.53
1.7
1.4
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
6
39
1.55
0.53
1.2
1.1
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
250
2449
1.39
0.53
30.7
19.4
e12/l
4.6
4.5
0.47
245
2382
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
9
65
1.40
0.51
1.6
1.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
14
101
1.41
0.50
3.6
3.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
28
226
1.27
0.50
1.3
1.3
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
23
181
1.30
0.50
2.1
3.4
e9/l
71.2
70.4
0.03
16
134
(3001019) Free T4 and TSH panel - Serum or Plasma
7
110
0.63
0.49
1.6
1.7
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
7
48
1.47
0.47
2.0
1.7
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
5
31
1.62
0.43
1.2
2.2
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
35
297
1.21
0.42
1.7
2.6
ug/g
52.1
128.7
3.41
29
238
(4281824)
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(4146454)
0
16
0.00
0.41
0.0
2.9
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
5
34
1.48
0.40
1.2
2.1
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
18
0.00
0.40
0.0
1.7
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
0
18
0.00
0.40
0.0
1.3
—
6.8
—
0
13
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
5
36
1.40
0.38
1.0
1.2
u/l
10.6
12.5
—
5
30
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
6
42
1.44
0.36
1.2
1.9
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
6
43
1.40
0.35
1.5
1.2
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
15
118
1.29
0.34
12.2
12.8
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
7
56
1.26
0.29
1.1
2.3
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
11
85
1.31
0.28
1.6
1.7
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
11
138
0.79
0.26
1.0
1.1
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
23
198
1.18
0.25
3.9
3.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
9
75
1.21
0.25
1.4
1.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
213
2086
1.11
0.24
5.0
4.3
mmol/l
4.7
4.7
0.11
205
1955
(40768800) Prostate Pathology biopsy report
5
39
1.29
0.23
1.0
1.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
7
95
0.73
0.22
1.0
1.5
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
5
40
1.25
0.22
2.6
2.8
mmol/l
9.4
8.0
—
5
40
(3050129) First trimester maternal screen panel - Serum or Plasma
5
41
1.22
0.22
2.2
1.4
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
153
1481
1.08
0.22
5.1
3.4
u/l
61.8
48.2
0.61
145
1404
(3000764) Benzodiazepines [Presence] in Urine
8
101
0.79
0.21
1.0
1.5
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
8
101
0.79
0.21
1.0
1.5
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
8
102
0.78
0.21
1.0
1.5
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
8
102
0.78
0.21
1.0
1.5
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
0
11
0.00
0.21
0.0
2.0
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
11
0.00
0.21
0.0
3.9
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
0
11
0.00
0.21
0.0
2.1
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.2
—
79.9
—
0
10
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
0
10
0.00
0.21
0.0
3.0
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
10
0.00
0.21
0.0
7.7
—
—
—
0
0
(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
0.6
—
0
7
(3024932) HLA-DR beta [Type]
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3024471) HLA-A [Type]
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
11.3
—
7.4
—
0
12
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
43
1.17
0.21
1.2
1.1
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
6
48
1.26
0.20
2.3
4.2
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
6
50
1.20
0.20
2.3
2.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
41
377
1.10
0.19
1.7
1.8
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
204
2003
1.08
0.18
4.6
3.8
mmol/l
1.4
1.3
0.76
195
1856
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
5
66
0.75
0.17
1.6
1.5
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
8
68
1.18
0.17
1.3
1.4
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
55
584
0.93
0.16
2.0
1.7
mmol/l
1.5
1.4
0.30
47
497
(1001926) Buprenorphine [Presence] in Urine by Screen method
6
79
0.75
0.15
1.0
1.4
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
215
2120
1.08
0.14
5.4
4.7
mmol/l
2.8
2.8
0.12
206
1969
(3003694) ABO and Rh group [Type] in Blood
61
580
1.07
0.14
1.2
1.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
28
304
0.91
0.13
1.6
1.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
20
220
0.90
0.12
1.7
1.6
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
15
166
0.90
0.10
1.3
1.7
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
37
351
1.06
0.09
2.8
2.7
ug/l
0.7
0.7
0.09
23
216
(40768793) Breast Pathology biopsy report
6
54
1.11
0.09
1.2
1.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
27
253
1.07
0.09
1.9
2.0
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
6
57
1.05
0.08
1.3
1.3
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
7
66
1.06
0.08
1.0
1.1
—
0.9
—
0
8
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
24
226
1.07
0.07
1.9
1.9
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
19
177
1.08
0.07
3.7
3.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
152
1500
1.03
0.06
3.1
3.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
25
257
0.97
0.01
1.3
1.6
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
208
2074
1.01
0.00
5.0
4.2
mmol/l
1.4
1.5
0.06
198
1929
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
12
116
1.04
0.00
1.4
2.0
—
—
—
0
0
(1002224) Polysomnography panel
10
105
0.95
0.00
1.2
1.1
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3012565) Volume of 24 hour Urine
0
9
0.00
0.00
0.0
2.7
—
2605.6
—
0
9
(3002619) Bacteria identified in Specimen by Culture
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.6
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
2.0
—
53.6
—
0
9
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(4094501)
6
59
1.02
0.00
1.3
1.1
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
0
5
0.00
0.00
0.0
4.4
—
53.4
—
0
5
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
5
51
0.98
0.00
2.4
1.3
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
16.3
—
0
5
(3024891) Influenza virus A+B Ag [Presence] in Specimen
7
72
0.97
0.00
1.1
1.2
—
—
—
0
0
(44806420)
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(44806071)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3035880) pH of Pleural fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
13
130
1.00
0.00
1.4
1.3
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
9
90
1.00
0.00
1.9
2.0
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
6
64
0.94
0.00
1.2
1.8
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
9.9
—
0
6
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
9
95
0.95
0.00
1.2
2.0
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
2.1
—
0
5
(3022689) Creatine [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
2.8
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint G6_MUSCOTHUNS and mortality.

Females

Parameter HR [95% CI] p-value
G6_MUSCOTHUNS 2.962 [2.19, 4.0] < 0.001
Birth year 0.992 [0.98, 1.0] 0.081

During the follow-up period (1.1.1998 — 31.12.2019), 136 out of 719 females with G6_MUSCOTHUNS died.

Males

Parameter HR [95% CI] p-value
G6_MUSCOTHUNS 2.651 [2.11, 3.34] < 0.001
Birth year 0.987 [0.98, 1.0] 0.024

During the follow-up period (1.1.1998 — 31.12.2019), 181 out of 773 males with G6_MUSCOTHUNS died.

Mortality risk

Mortality risk for people of age

years, who have G6_MUSCOTHUNS.

N-year risk Females Males
1 0.252% 0.384%
5 1.66% 2.69%
10 3.948% 6.826%
15 7.418% 13.381%
20 12.42% 22.845%

Relationships between endpoints

↥

Index endpoint: G6_MUSCOTHUNS – Other and unspecified primary disorders of muscles

GWS hits: 9

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data